Name: staining protocols for human pancreatic islets
Uploaded: 2012-05-23T13:00:00
Description: Watch this Scientific Journal Video about Staining Protocols for Human Pancreatic Islets at JoVE.com

Författarna tackar givarna familjer och orgeln organisationer för tillvaratagande inblandade i denna forskning och Emily Montgomery, Robert Pietras, Ann Fu, Mitali Agarwal och Roshan Agarwal för deras experthjälp. Detta arbete har finansierats av Juvenile Diabetes Research Foundation (MC-T.) till stöd för nätverket för givare bukspottkörtel Organ med diabetes.

1. Mikrotomi för Ofärgade avsnitten <ol><li> Ställ in vattenbad och mikrotom som för standard paraffin mikrotomi. Använd positivt laddade bilder och pre-etikett med målnummer, pankreas-regionen (prov) och bildnummer. Plats paraffin-block i mikrotomen chucken med kassetten etiketten på den vänstra sidan. </li><li> Följ normala mikrotomi förfaranden, avsnitt in i blocket tills vävnaden är jämnt påträffas. Skapa ett band av seriella sektioner (4 m tjocka, 3-6 beroende på antalet ursprungliga nödvändiga ...

<ol>
	<li>In't Veld, P., Marichal, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microscopic+anatomy+of+the+human+islet+of+Langerhans.">Microscopic anatomy of the human islet of Langerhans.</a> Adv. Exp. Med. Biol. 654, 1-19 (2010).</li><li>Matveyenko, A. V., Butler, P. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Relationship+between+beta-cell+mass+and+diabetes+onset.">Relationship between beta-cell mass and diabetes onset.</a> Diabetes Obes. Metab. 10, 23-31 (2008).</li><li>Saisho, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pancreas+volumes+in+humans+from+birth+to+age+one+hundred+taking+into+account+sex,+obesity,+and+presence+of+type-2+diabetes.">Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes.</a> Clin. Anat. 20, 933-942 (2007).</li><li>Hruban, R. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pancreatic+intraepithelial+neoplasia:+a+new+nomenclature+and+classification+system+for+pancreatic+duct+lesions.">Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.</a> Am. J. Surg. Pathol. 25, 579-586 (2001).</li><li>Campbell-Thompson, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pancreatic+adenocarcinoma+patients+with+localised+chronic+severe+pancreatitis+show+an+increased+number+of+single+beta+cells,+without+alterations+in+fractional+insulin+area.">Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area.</a> Diabetologia. 52, 262-270 (2009).</li><li>Meier, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Beta-cell+replication+is+the+primary+mechanism+subserving+the+postnatal+expansion+of+beta-cell+mass+in+humans.">Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.</a> Diabetes. 57, 1584-1594 (2008).</li><li>Rowe, P. A., Campbell-Thompson, M. L., Schatz, D. A., Atkinson, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+pancreas+in+human+type+1+diabetes.">The pancreas in human type 1 diabetes.</a> Semin. Immunopathol. 33, 29-43 (2011).</li><li>Veld, I. n. '. t., P, . <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Insulitis+in+human+type+1+diabetes:+The+quest+for+an+elusive+lesion.">Insulitis in human type 1 diabetes: The quest for an elusive lesion.</a> Islets. 3, 131-138 (2011).</li><li>van Belle, T. L., Coppieters, K. T., von Herrath, M. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Type+1+diabetes:+etiology,+immunology,+and+therapeutic+strategies.">Type 1 diabetes: etiology, immunology, and therapeutic strategies.</a> Physiol Rev. 91, 79-118 (2011).</li></ol>

Standardisering av IHC förfaranden är kritisk för bildanalys, speciellt vid användning av dator-baserade algoritmer i stora mängder glider över tiden. IHC färgning som beskrivs i denna rapport kan parti analys av en viss givares prover med en Autostainer inom en 8-timmars arbetsdag och ändras från en tidigare rapport 5. Digitaliserade hela glaset bilder av varje färgade bild görs tillgänglig för nPOD-anslutna utredare genom det webbaserade online-patologi system. Utredarna kan granska givare demo...

<table border="1"><tbody><tr><td> Namnet på reagens </td><td> Företaget </td><td> Katalognummer </td><td> Kommentarer </td></tr><tr><td> 30% väteperoxid (H 2 O 2) </td><td> FisherScientific </td><td> H325-500 </td><td> Endogent peroxidas blockerande </td></tr><tr><td> ABC-alkaliskt fosfatas (AP) </td><td> Vektor </td><td> AK-5000 </td><td> AP-konjugatet </td></tr><tr><td> Antikropp Utspädningsmedel </td><td> Invitrogen </td><td> 003.218 </td><td> Primär antikropp </td></tr><tr><td> Avidin blockerare </td><td> Vektor </td><td> SP-2001 </td><td> Blockera endogen biotin </td></tr><tr><td> Biotinylerat get-anti-marsvins- </td><td> Vektor </td><td> BA-7000 </td><td> Sekundär antikropp </td></tr><tr><td> Blåelse Reagens </td><td> FisherScientific </td><td> 7301 </td><td> Leica autostainer </td></tr><tr><td> Citratbuffert, pH 6,0 </td><td> BioGenex </td><td> HK086-9K </td><td> Antigenåtervinning </td></tr><tr><td> Klarningsanordningen 1 </td><td> FisherScientific </td><td> 7401 </td><td> Leica Autostainer </td></tr><tr><td> Cytoseal XYL </td><td> FisherScientific </td><td> 8312-4 </td><td> Täckglas monteringsvätska </td></tr><tr><td> DAB </td><td> Vektor </td><td> SK-4100 </td><td> HRP kromogen </td></tr><tr><td> Deeb </td><td> DAKO </td><td> S2003 </td><td> Endogent AP blockeringsreagens </td></tr><tr><td> Eosin Y Alkoholhaltig </td><td> FisherScientific </td><td> 71.204 </td><td> Leica Autostainer </td></tr><tr><td> Etanoler-100%, 95%, 90%, 70% </td><td> FisherScientific </td><td> Olika </td><td> Deparaffinization och täckglas </td></tr><tr><td> Hematoxylin </td><td> DAKO </td><td> S3301 </td><td> Dako Autostainer </td></tr><tr><td> Hematoxylin 7211 </td><td> FisherScientific </td><td> 7211 </td><td> Leica Autostainer </td></tr><tr><td> IgG (alla värdarter för primära antikroppar) </td><td> Olika </td><td> Olika </td><td> Negativa kontroller för primärfärger </td></tr><tr><td> Liquid Permanent Red (LPR) </td><td> DAKO </td><td> K0640 </td><td> AP kromogen </td></tr><tr><td> Mach2 AP </td><td> Biocare Medical </td><td> MALP521L </td><td> Get-anti-mus AP-konjugatet </td></tr><tr><td> Mach2 HRP </td><td> Biocare Medical </td><td> MHRP520L </td><td> Get-anti-mus-HRP-konjugat </td></tr><tr><td> Mach2 HRP </td><td> Biocare Medical </td><td> RHRP520L </td><td> Get-anti-mus-HRP-konjugat </td></tr><tr><td> Metanol </td><td> FisherScientific </td><td> Olika </td><td> H 2 O 2 utspädningsmedel </td></tr><tr><td> Normalt getserum </td><td> Vektor </td><td> S-1000 </td><td> IHC blockeringsreagens </td></tr><tr><td> Sniper </td><td> Biocare Medical </td><td> BS966M </td><td> IHC blockeringsreagens </td></tr><tr><td> TBST 20X </td><td> ThermoScientific </td><td> TA-999-TT </td><td> IHC buffert </td></tr><tr><td> Trilogi 20x </td><td> Cell Marque </td><td> 920P-06 </td><td> Antigenåtervinning </td></tr><tr><td> Xylen </td><td> FisherScientific </td><td> Olika </td><td> Deparaffinization och täckglas </td></tr></tbody></table> Tabell 1. Specifika reagens. <table border="1"><tbody><tr><td> Primär antikropp </td><td> Värdarter </td><td> Leverantör </td><td> Kat. # </td><td> Kommentarer och antigenåtervinning </td></tr><tr><td> Fotogen </td><td></td><td></td><td></td><td></td></tr><tr><td> Amylas </td><td> Mus </td><td> Santa Cruz </td><td> SC-46.657 </td><td> Citrat </td></tr><tr><td> Amylin </td><td> Mus </td><td> Serotec </td><td> MCA11267 </td><td> Citrat </td></tr><tr><td> Karbanhydras 19,9 </td><td> Mus </td><td> Abcam </td><td> ab15146 </td><td></td></tr><tr><td> Kaspas-3, klövs </td><td> Kanin </td><td> Cellsignalering </td><td> 9961 </td><td> Citrat eller Trilogy </td></tr><tr><td> CD20 </td><td> Mus </td><td> DAKO </td><td> M0755 </td><td> Citrat eller Trilogy </td></tr><tr><td> CD3 </td><td> Kanin </td><td> DAKO </td><td> A0452 </td><td> Citrat </td></tr><tr><td> CD34 </td><td> Mus </td><td> Cellsignalering </td><td> 3569 </td><td> Citrat </td></tr><tr><td> CD4 </td><td> Mus </td><td> DAKO </td><td> M7310 </td><td> Citrat </td> &lt;/ Tr&gt; <tr><td> CD45 </td><td> Mus </td><td> DAKO </td><td> M0754 </td><td> Citrat </td></tr><tr><td> CD68 </td><td> Mus </td><td> DAKO </td><td> M0876 </td><td> Citrat </td></tr><tr><td> CD8 </td><td> Mus </td><td> DAKO </td><td> M7103 </td><td> Citrat </td></tr><tr><td> Kromogranin A </td><td> Kanin </td><td> DAKO </td><td> A0430 </td><td> Citrat </td></tr><tr><td> CK17 </td><td> Mus </td><td> DAKO </td><td> M7046 </td><td> Citrat </td></tr><tr><td> CK19 </td><td> Mus </td><td> DAKO </td><td> M0772 </td><td> Citrat </td></tr><tr><td> CK7 </td><td> Mus </td><td> DAKO </td><td> M7018 </td><td> Citrat </td></tr><tr><td> C-peptid </td><td> Kanin </td><td> Cellsignalering </td><td> 4593 </td><td> Citrat </td></tr><tr><td> FOXP3 </td><td> Råtta </td><td> e Bioscience </td><td> 14-4776-80 </td&gt; <td> Citrat </td></tr><tr><td> Ghrelin </td><td> Get </td><td> Santa Cruz </td><td> SC-10.386 </td><td></td></tr><tr><td> Ghrelin </td><td> Kanin </td><td> Abcam </td><td> ab85104 </td><td></td></tr><tr><td> Glukagon </td><td> Kanin </td><td> DAKO </td><td> A0565 </td><td></td></tr><tr><td> Glukagon </td><td> Mus </td><td> Abcam </td><td> ab10988 </td><td> Citrat </td></tr><tr><td> Glukagon </td><td> Marsvin </td><td> Bachem </td><td> T-5037 </td><td> Citrat </td></tr><tr><td> GLUT-1 </td><td> Mus </td><td> Abcam </td><td> ab40084 </td><td> Trilogy </td></tr><tr><td> GLUT-2 </td><td> Kanin </td><td> Santa Cruz </td><td> SC-9117 </td><td> Inte uttrycks i humana öar </td></tr><tr><td> Insulin </td><td> Marsvin </td><td> DAKO </td><td> A0564 </td><td></td></tr> &lt;tr&gt; <td> Ki-67 </td><td> Mus </td><td> DAKO </td><td> M7240 </td><td> Citrat </td></tr><tr><td> MAFA </td><td> Kanin </td><td> Novus Biologisk </td><td> NB400-137A </td><td> Trilogy </td></tr><tr><td> Pankreatisk polypeptid </td><td> Kanin </td><td> Invitrogen </td><td> 18-0043 </td><td> Citrat </td></tr><tr><td> PDX-1 </td><td> Marsvin </td><td> Abcam </td><td> ab47308 </td><td> Citrat eller Trilogy </td></tr><tr><td> Proinsulin </td><td> Mus </td><td> Novocastra </td><td> GLA-proin-1G4 </td><td></td></tr><tr><td> Proinsulin </td><td> Mus </td><td> Developmental Studies Hybridoma Bank </td><td> GS-9A8 </td><td> Citrat </td></tr><tr><td> Secretagogin </td><td> Kanin </td><td> Sigma </td><td> HPA 006.641 </td><td> Citrat </td></tr><tr><td> Glattmuskelaktin </td><td> Kanin </td><td> Abcam </td><td> ab5694 &lt;/ Td&gt; <td></td></tr><tr><td> Somatostatin </td><td> Kanin </td><td> DAKO </td><td> A0566 </td><td></td></tr><tr><td> Synaptophysin </td><td> Mus </td><td> DAKO </td><td> M0776 </td><td> Citrat </td></tr><tr><td> Färskfrusen </td><td> Värdarter </td><td> Leverantör </td><td> Kat. # </td><td> Kommentarer </td></tr><tr><td> CD11b </td><td> Råtta </td><td> Abcam </td><td> ab6332 </td><td> Fäst med 4% PF </td></tr><tr><td> CD11c </td><td> Kanin </td><td> Serotec </td><td> AHP1226 </td><td></td></tr><tr><td> CD25 </td><td> Mus </td><td> Novus Biologisk </td><td> Anm 600-564 </td><td> Använd natten inkubation paraffinsektioner </td></tr><tr><td> CD94 </td><td> Mus </td><td> Abcam </td><td> ab61874 </td><td> Fäst med aceton </td></tr><tr><td> GAD65 </td><td> Mus </td><td> Santa Cruz </td><td> SC-130.569 </td><td> Fäst med 4% PF </td></tr><tr><td> HLA-ABC </td><td> Mus </td><td> DAKO </td><td> M0736 </td><td> Fäst med aceton eller 4% PF </td></tr></tbody></table> Tabell 2. Primära antikroppar. <table border="1"><tbody><tr><td> Namnet på reagens </td><td> Företaget </td><td> Katalognummer </td><td> Kommentarer </td></tr><tr><td> Aperio Scanscope CS </td><td> Aperio </td><td></td><td> Digital diascanner </td></tr><tr><td> DAKO Autostainer Plus </td><td> DAKO </td><td></td><td> IHC fläckar </td></tr><tr><td> Label Matrix skrivarprogrammet </td><td> BioCarta </td><td> LM7UP57 </td><td> Slide Label Software </td></tr><tr><td> Leica XL Autostainer </td><td>Leica </td><td></td><td> H &amp; E fläckar </td></tr><tr><td> Premium täckglas </td><td> FisherScientific </td><td> 12-548-5J </td><td> Täckglas </td></tr><tr><td> Spectrum Information Manager </td><td> Aperio </td><td></td><td> Skannerprogrammet </td></tr><tr><td> SuperFrost Plus glider </td><td> FisherScientific </td><td> 12-550-15 </td><td> Positivt laddade bilder </td></tr><tr><td> Vegetabilisk ångare </td><td> Black and Decker </td><td> Olika </td><td> Antigenåtervinning </td></tr><tr><td> Zebra TLP 3742 </td><td> CDWG </td><td> TLP3742 </td><td> Slide etikettskrivare </td></tr></tbody></table> Tabell 3. Särskilda förnödenheter och utrustning.

staining protocols for human pancreatic islets

Uppskattningar av ö-område och antalet och endokrina celler komposition i vuxen human pankreas variera från flera hundra tusen till flera miljoner och beta massa ligger i intervallet från 500 till 1500 mg 1-3. Med denna kända heterogenitet, var en vanlig behandling och färgningsproceduren utvecklas så att bukspottkörteln regioner var tydligt definierade och holmar kännetecknas med rigorös histopatologi och undersökningar immunolokalisering. Standardiserade förfaranden för bearbetning av mänskliga bukspottkörteln återhämtat sig från organdonatorer beskrivs i del 1 av denna serie. Bukspottkörteln är bearbetas i 3 huvudsakliga områden (huvud, kropp, svans) följt av tvärgående sektioner. Tvärgående snitt från bukspottkörteln huvudet är vidare uppdelade, som anges baserat på storlek, och numrerade alfabetiskt att beteckna underavdelningar. Denna standardisering möjliggör en fullständig tvärsektion analys av huvudet regionen inklusive uncinate region som innehåller sammansatta cellöarprimärt av pankreatisk polypeptid celler till svansregionen. Den här rapporten utgör en del 2 i denna serie och beskriver de förfaranden som används för seriell sektionering och histopatologiska karakterisering av avsnitten pankreas paraffin med en betoning på ö endokrina celler, replikering och T-cellinfiltrat. Patologi pankreas sektioner är avsedd att karakterisera både exokrin, duktulära, och komponenter endokrina. Den exokrina facket utvärderas med avseende på närvaro av pankreatit (aktiv eller kronisk), atrofi, fibros, och fett, liksom kanalsystemet, i synnerhet i relation till närvaron av pankreatisk intraduktal neoplasi 4. Cellöarna utvärderades med avseende på morfologi, storlek och densitet, celler endokrina, inflammation, fibros, amyloid, och närvaron av replikerande eller apoptotiska celler med användning av H &amp; E och IHC fläckar. Den sista komponenten beskrivs i del 2 är tillhandahållandet av färgade bildens som digitaliserade hela glaset bilder. De digitaliserade bilderna är organiserade från fall till fall och bukspottkörtel region i en online-databas patologi skapa en virtuell biobank. Tillgång till detta online kollektion tillhandahålls för närvarande till över 200 kliniker och forskare som deltar i typ 1-diabetes forskning. Online databasen ger ett medel för snabb och fullständig datadelning och utredarna att välja block för paraffin eller frysta seriella sektioner.

Watch this Scientific Journal Video about Staining Protocols for Human Pancreatic Islets at JoVE.com

Staining Protocols for Human Pancreatic Islets

Denna video demonstrerar förfaranden för karakterisering av humana pankreasöar med hematoxylin och eosin (H &amp; E) och immunohistokemi (IHC). Pankreatiska sektioner från huvud, kropp och regioner svans färgas av både H &amp; E och IHC för att bestämma ö endokrin sammansättning (insulin, glukagon och pankreaspolypeptid), cellreplikation (Ki67) och inflammatoriska infiltrat (H &amp; E, CD3). Den uncinate regionen är lokaliserad användning IHC för pankreatisk polypeptid.

Färgning Protokoll för mänskliga pankreatiska öar

Estimates of islet area and numbers and endocrine cell composition in the adult human pancreas vary from several hundred thousand to several million and ...

staining-protocols-for-human-pancreatic-islets

Research

JoVE Journal

Medicine

Isolation of Human Islets from Partially Pancreatectomized Patients

Investigations into the pathogenesis of type 2 diabetes and islets of Langerhans malfunction 1 have been hampered by the limited availability of type 2 diabetic islets from organ donors2. Here we share our protocol for isolating islets from human pancreatic tissue obtained from type 2 diabetic and non-diabetic patients who have undergone partial pancreatectomy due to different pancreatic diseases (benign or malignant pancreatic tumors, chronic pancreatitis, and common bile duct or duodenal tumors). All patients involved gave their consent to this study, which had also been approved by the local ethics committee. The surgical specimens were immediately delivered to the pathologist who selected soft and healthy appearing pancreatic tissue for islet isolation, retaining the damaged tissue for diagnostic purposes. We found that to isolate more than 1,000 islets, we had to begin with at least 2 g of pancreatic tissue. Also essential to our protocol was to visibly distend the tissue when injecting the enzyme-containing media and subsequently mince it to aid digestion by increasing the surface area.
To extend the applicability of our protocol to include the occasional case in which a large amount (&gt;15g) of human pancreatic tissue is available , we used a Ricordi chamber (50 ml) to digest the tissue. During digestion, we manually shook the Ricordi chamber3 at an intensity that varied by specimen according to its level of tissue fibrosis. A discontinous Ficoll gradient was then used to separate the islets from acinar tissue. We noted that the tissue pellet should be small enough to be homogenously resuspended in Ficoll medium with a density of 1.125 g/ml. After isolation, we cultured the islets under stress free conditions (no shaking or rotation) with 5% CO2 at 37 &deg;C for at least 48 h in order to facilitate their functional recovery. Widespread application of our protocol and its future improvement could enable the timely harvesting of large quantities of human islets from diabetic and clinically matched non-diabetic subjects, greatly advancing type 2 diabetes research.

The supply of type 2 diabetic islets for research is insufficient. Here we share our protocol for isolating islets from patients undergoing partial pancreatectomy. This approach represents a unique venue for obtaining islets from type 2 diabetic and clinically matched non-diabetic subjects in adequate numbers for basic and clinical studies.

Isolering av mänskliga Islets från Delvis Pancreatectomized Patienter

Investigations into the pathogenesis of type 2 diabetes and islets of Langerhans malfunction 1 have been hampered by the limited availability of type 2 ...

Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

B7-H1/PD-L1, a member of the B7 family of immune-regulatory cell-surface proteins, plays an important role in the negative regulation of cell-mediated immune responses through its interaction with its receptor, programmed death-1 (PD-1) 1,2. Overexpression of B7-H1 by tumor cells has been noted in a number of human cancers, including melanoma, glioblastoma, and carcinomas of the lung, breast, colon, ovary, and renal cells, and has been shown to impair anti-tumor T-cell immunity3-8.
Recently, B7-H1 expression by pancreatic adenocarcinoma tissues has been identified as a potential prognostic marker9,10. Additionally, blockade of B7-H1 in a mouse model of pancreatic cancer has been shown to produce an anti-tumor response11. These data suggest the importance of B7-H1 as a potential therapeutic target. Anti-B7-H1 blockade antibodies are therefore being tested in clinical trials for multiple human solid tumors including melanoma and cancers of lung, colon, kidney, stomach and pancreas12.
In order to eventually be able to identify the patients who will benefit from B7-H1 targeting therapies, it is critical to investigate the correlation between expression and localization of B7-H1 and patient response to treatment with B7-H1 blockade antibodies. Examining the expression of B7-H1 in human pancreatic adenocarcinoma tissues through immunohistochemistry will give a better understanding of how this co-inhibitory signaling molecule contributes to the suppression of antitumor immunity in the tumor's microenvironment. The anti-B7-H1 monoclonal antibody (clone 5H1) developed by Chen and coworkers has been shown to produce reliable staining results in cryosections of multiple types of human neoplastic tissues4,8, but staining on paraffin-embedded slides had been a challenge until recently13-18. We have developed the B7-H1 staining protocol for paraffin-embedded slides of pancreatic adenocarcinoma tissues. The B7-H1 staining protocol described here produces consistent membranous and cytoplasmic staining of B7-H1 with little background.

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

B7-H1 (PD-L1) and its binding to PD-1 provide a major tumor-induced immunosuppressive signal in the tumor&#x2019;s microenvironment. An immunohistochemical staining technique to characterize the expression and localization of B7-H1 in pancreatic adenocarcinoma is described here.

Immunhistokemisk färgning av B7-H1 (PD-L1) på Paraffininbäddade Bilder av Pancreatic Adenocarcinom Tissue

B7-H1/PD-L1, a member  of the B7 family of immune-regulatory cell-surface proteins, plays an important  role in the negative regulation of cell-mediated ...

Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction

Orthotopic liver transplantation (OLT) in rats using a whole or partial graft is an indispensable experimental model for transplantation research, such as studies on graft preservation and ischemia-reperfusion injury 1,2, immunological responses 3,4, hemodynamics 5,6, and small-for-size syndrome 7. The rat OLT is among the most difficult animal models in experimental surgery and demands advanced microsurgical skills that take a long time to learn. Consequently, the use of this model has been limited. Since the reliability and reproducibility of results are key components of the experiments in which such complex animal models are used, it is essential for surgeons who are involved in rat OLT to be trained in well-standardized and sophisticated procedures for this model.
While various techniques and modifications of OLT in rats have been reported 8 since the first model was described by Lee et al. 9 in 1973, the elimination of the hepatic arterial reconstruction 10 and the introduction of the cuff anastomosis technique by Kamada et al. 11 were a major advancement in this model, because they simplified the reconstruction procedures to a great degree. In the model by Kamada et al., the hepatic rearterialization was also eliminated. Since rats could survive without hepatic arterial flow after liver transplantation, there was considerable controversy over the value of hepatic arterialization. However, the physiological superiority of the arterialized model has been increasingly acknowledged, especially in terms of preserving the bile duct system 8,12 and the liver integrity 8,13,14.
In this article, we present detailed surgical procedures for a rat model of OLT with hepatic arterial reconstruction using a 50% partial graft after ex vivo liver resection. The reconstruction procedures for each vessel and the bile duct are performed by the following methods: a 7-0 polypropylene continuous suture for the supra- and infrahepatic vena cava; a cuff technique for the portal vein; and a stent technique for the hepatic artery and the bile duct.

Orthotopic liver transplantation in rats is an indispensable experimental model for biomedical research. Here we present our surgical procedures for orthotopic rat liver transplantation with hepatic arterial reconstruction using a 50% partial graft.

Kirurgiska ingrepp för en råttmodell av partiella ortotop levertransplantation med nedsatt arteriell rekonstruktion

Orthotopic liver transplantation (OLT) in rats using a whole or partial graft is an indispensable experimental model for transplantation research, such as ...

Improved Protocol For Laser Microdissection Of Human Pancreatic Islets From Surgical Specimens

Laser microdissection (LMD) is a technique that allows the recovery of selected cells and tissues from minute amounts of parenchyma 1,2. The dissected cells can be used for a variety of investigations, such as transcriptomic or proteomic studies, DNA assessment or chromosomal analysis 2,3. An especially challenging application of LMD is transcriptome analysis, which, due to the lability of RNA 4, can be particularly prominent when cells are dissected from tissues that are rich of RNases, such as the pancreas. A microdissection protocol that enables fast identification and collection of target cells is essential in this setting in order to shorten the tissue handling time and, consequently, to ensure RNA preservation. 
Here we describe a protocol for acquiring human pancreatic beta cells from surgical specimens to be used for transcriptomic studies 5. Small pieces of pancreas of about 0.5-1 cm3 were cut from the healthy appearing margins of resected pancreas specimens, embedded in Tissue-Tek O.C.T. Compound, immediately frozen in chilled 2-Methylbutane, and stored at -80 &deg;C until sectioning. Forty serial sections of 10 &mu;m thickness were cut on a cryostat under a -20 &deg;C setting, transferred individually to glass slides, dried inside the cryostat for 1-2 min, and stored at -80 &deg;C. 
Immediately before the laser microdissection procedure, sections were fixed in ice cold, freshly prepared 70% ethanol for 30 sec, washed by 5-6 dips in ice cold DEPC-treated water, and dehydrated by two one-minute incubations in ice cold 100% ethanol followed by xylene (which is used for tissue dehydration) for 4 min; tissue sections were then air-dried afterwards for 3-5 min. Importantly, all steps, except the incubation in xylene, were performed using ice-cold reagents - a modification over a previously described protocol 6. utilization of ice cold reagents resulted in a pronounced increase of the intrinsic autofluorescence of beta cells, and facilitated their recognition. For microdissection, four sections were dehydrated each time: two were placed into a foil-wrapped 50 ml tube, to protect the tissue from moisture and bleaching; the remaining two were immediately microdissected. This procedure was performed using a PALM MicroBeam instrument (Zeiss) employing the Auto Laser Pressure Catapulting (AutoLPC) mode. The completion of beta cell/islet dissection from four cryosections required no longer than 40-60 min. Cells were collected into one AdhesiveCap and lysed with 10 &mu;l lysis buffer. Each single RNA specimen for transcriptomic analysis was obtained by combining 10 cell microdissected samples, followed by RNA extraction using the Pico Pure RNA Isolation Kit (Arcturus). This protocol improves the intrinsic autofluorescence of human beta cells, thus facilitating their rapid and accurate recognition and collection. Further improvement of this procedure could enable the dissection of phenotypically different beta cells, with possible implications for better understanding the changes associated with type 2 diabetes.

Laser microdissection is a technique that allows the recovery of selected cells from minute amounts of parenchyma. Here we describe a protocol for acquiring human pancreatic islets from surgical specimens to be used for transcriptomic studies. Our protocol improves the intrinsic autofluorescence of human beta cells, thus facilitating their collection.

Förbättrad protokoll för laser mikrodissektion av humana pankreasöar från kirurgiska prover

Laser microdissection (LMD) is a technique that allows the recovery of selected cells and tissues from minute amounts of parenchyma 1,2. The dissected ...

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Pancreatic cancer has an extremely poor five-year survival rate of 4-6%. New therapeutic options are critically needed and depend on improved understanding of pancreatic cancer biology. To better understand the interaction of cancer cells with the pancreatic microenvironment, we demonstrate an orthotopic model of pancreatic cancer that permits non-invasive monitoring of cancer progression. Luciferase-tagged pancreatic cancer cells are resuspended in Matrigel and delivered into the pancreatic tail during laparotomy. Matrigel solidifies at body temperature to prevent leakage of cancer cells during injection. Primary tumor growth and metastasis to distant organs are monitored following injection of the luciferase substrate luciferin, using in vivo imaging of bioluminescence emission from the cancer cells. In vivo imaging also may be used to track primary tumor recurrence after resection. This orthotopic model is suited to both syngeneic and xenograft models and may be used in pre-clinical trials to investigate the impact of novel anti-cancer therapeutics on the growth of the primary pancreatic tumor and metastasis.

Improved understanding of pancreatic cancer biology is critically needed to enable the development of better therapeutic options to treat pancreatic cancer. To address this need, we demonstrate an orthotopic model of pancreatic cancer that permits non-invasive monitoring of cancer progression using in vivo bioluminescence imaging.

Bioluminescent Orthotopic Modell av bukspottkörtelcancer Progression

Pancreatic cancer has an extremely poor five-year survival rate of 4-6%.  New therapeutic options are critically needed and depend on improved ...

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment

The use of ex vivo perfused models can mimic the physiological conditions of the liver for short periods, but to maintain normal homeostasis for an extended perfusion period is challenging. We have added the kidney to our previous ex vivo perfused liver experiment model to reproduce a more accurate physiological state for prolonged experiments without using live animals. Five intact livers and kidneys were retrieved post-mortem from sacrificed pigs on different days and perfused for a minimum of 6 hr. Hourly arterial blood gases were obtained to analyze pH, lactate, glucose and renal parameters. The primary endpoint was to investigate the effect of adding one kidney to the model on the acid base balance, glucose, and electrolyte levels. The result of this liver-kidney experiment was compared to the results of five previous liver only perfusion models. In summary, with the addition of one kidney to the ex vivo liver circuit, hyperglycemia and metabolic acidosis were improved. In addition this model reproduces the physiological and metabolic responses of the liver sufficiently accurately to obviate the need for the use of live animals. The ex vivo liver-kidney perfusion model can be used as an alternative method in organ specific studies. It provides a disconnection from numerous systemic influences and allows specific and accurate adjustments of arterial and venous pressures and flow.

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment

Study of the animal organ physiology can be achieved by performing an experimental ex vivo perfusion system. The addition of a porcine kidney, as a homeostatic organ to our previously developed ex vivo liver perfusion model can be a principal step to achieve a better physiological environment.

The use of ex vivo perfused models can mimic the physiological conditions of the liver for short periods, but to maintain normal homeostasis for an ...

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters

For almost 30 years, scientists have demonstrated that human fetal ICCs transplanted under the kidney capsule of nude mice matured into functioning endocrine cells, as evidenced by a significant increase in circulating human C-peptide following glucose stimulation1-9. However in vitro, genesis of insulin producing cells from human fetal ICCs is low10; results reminiscent of recent experiments performed with human embryonic stem cells (hESC), a renewable source of cells that hold great promise as a potential therapeutic treatment for type 1 diabetes. Like ICCs, transplantation of partially differentiated hESC generate glucose responsive, insulin producing cells, but in vitro genesis of insulin producing cells from hESC is much less robust11-17. A complete understanding of the factors that influence the growth and differentiation of endocrine precursor cells will likely require data generated from both ICCs and hESC. While a number of protocols exist to generate insulin producing cells from hESC in vitro11-22, far fewer exist for ICCs10,23,24. Part of that discrepancy likely comes from the difficulty of working with human fetal pancreas. Towards that end, we have continued to build upon existing methods to isolate fetal islets from human pancreases with gestational ages ranging from 12 to 23 weeks, grow the cells as a monolayer or in suspension, and image for cell proliferation, pancreatic markers and human hormones including glucagon and C-peptide. ICCs generated by the protocol described below result in C-peptide release after transplantation under the kidney capsule of nude mice that are similar to C-peptide levels obtained by transplantation of fresh tissue6. Although the examples presented here focus upon the pancreatic endoderm proliferation and &#946;&#160;cell genesis, the protocol can be employed to study other aspects of pancreatic development, including exocrine, ductal, and other hormone producing cells.

A protocol to isolate, culture, and image islet cell clusters (ICCs) derived from human fetal pancreatic cells is described.&#160; The method details the steps necessary to generate ICCs from tissue, culture as monolayers or in suspension as aggregates, and image for markers of proliferation and pancreatic cell fate decisions.

Isolering, kultur, och avbildning av Human Fetal Pankreas cell kluster

For almost 30 years, scientists have demonstrated that human fetal ICCs transplanted under the kidney capsule of nude mice matured into functioning ...

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Type 2 diabetes is a chronic disease affecting 382 million people in 2013, and is expected to rise to 592 million by 2035 1. During the past 2 decades, the role of beta-cell dysfunction in type 2 diabetes has been clearly established 2. Research progress has required methods for the isolation of pancreatic islets. The protocol of the islet isolation presented here shares many common steps with protocols from other groups, with some modifications to improve the yield and quality of isolated islets from both the wild type and diabetic Leprdb (db/db) mice. A live-cell 2-photon imaging method is then presented that can be used to investigate the control of insulin secretion within islets.

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

We present here a protocol for the isolation of islets from the mouse model of type 2 diabetes, Leprdb and details of a live-cell assay for measurement of insulin secretion from intact islets that utilizes 2 photon microscopy.

Lepr<sup&gt; Db</sup&gt; Musmodell av typ 2-diabetes: Pancreatic Islet Isolering och Live-cell 2-Photon Imaging av intakt cellöar

Type 2 diabetes is a chronic disease affecting 382 million people in 2013, and is expected to rise to 592 million by 2035 1. During the past 2 decades, ...

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Pancreatic islet transplantation to reduce hyperglycemia is highly successful in rodents with chemically-induced diabetes. The most common transplantation site in experimental islet transplantation is the kidney capsule. However, as less is known about the interaction of pancreatic islets with blood constituents, it also makes sense to utilize the portal vein approach in experimental islet transplantation.
This protocol demonstrates an intraportal islet transplantation technique in NMRI nude mice. Streptozotocin (180 mg/kg) is injected intraperitoneally to induce hyperglycemia in recipient mice. They are considered as diabetic at a non-fasting blood glucose level greater than 20 mmol/L. One day prior to transplantation, mouse pancreatic islets are isolated from the donor pancreas by collagenase digestion; a minimum of 350 islets are utilized per diabetic recipient. Depending upon the islet isolation yield, two or more donor mice are utilized per recipient. After overnight culture at 37 &#176;C, islets are administered into the recipient liver via the portal vein. After surgery, the mice are protected in red Makrolon houses and observed until are awake. This protocol maintains glycemic control for 120 days in syngeneic mice and 15 days in allogeneic mice.

Pancreatic islet transplantation is a way to achieve normoglycemia in type 1 diabetes. This article focuses on the transplantation technique through the intraportal route to maintain normal glucose levels in diabetic mice.

Intraportal Transplantation av Langerhanska i musmodell

Pancreatic islet transplantation to reduce hyperglycemia is highly successful in rodents with chemically-induced diabetes. The most common transplantation ...

Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay

Mitophagy is an essential mitochondrial quality control pathway, which is crucial for pancreatic islet beta cell bioenergetics to fuel glucose-stimulated insulin release. Assessment of mitophagy is challenging and often requires genetic reporters or multiple complementary techniques not easily utilized in tissue samples, such as primary human pancreatic islets. Here we demonstrate a robust approach to visualize and quantify formation of key endogenous mitophagy complexes in primary human pancreatic islets. Utilizing the sensitive proximity ligation assay technique to detect interaction of the mitophagy regulators NRDP1 and USP8, we are able to specifically quantify formation of essential mitophagy complexes in situ. By coupling this approach to counterstaining for the transcription factor PDX1, we can quantify mitophagy complexes, and the factors that can impair mitophagy, specifically within beta cells. The methodology we describe overcomes the need for large quantities of cellular extracts required for other protein-protein interaction studies, such as immunoprecipitation (IP) or mass spectrometry, and is ideal for precious human islet&#160;samples generally not available in sufficient quantities for these approaches. Further, this methodology obviates the need for flow sorting techniques to purify beta cells from a heterogeneous islet population for downstream protein applications. Thus, we describe a valuable protocol for visualization of mitophagy highly compatible for use in heterogeneous and limited cell populations.

This protocol outlines a method for quantitative analysis of mitophagy protein complex formation specifically in beta cells from primary human islet samples. This technique thus allows analysis of mitophagy from limited biological material, which are crucial in precious human pancreatic beta cell samples.

Visualisering av endogena Mitofagkomplex in situ i mänskliga bukspottskörteln beta celler använder närhet ligation assay

Mitophagy is an essential mitochondrial quality control pathway, which is crucial for pancreatic islet beta cell bioenergetics to fuel glucose-stimulated ...